Item 8.01 Other Events.

CVS Health Corporation ("CVS Health") issued a press release today announcing that it and its subsidiary CVS Pharmacy, Inc. ("CVS Pharmacy") have entered into a settlement agreement with the State of Florida to resolve claims related to prescriptions for opioid medications that were filled at CVS pharmacy locations in Florida. Under the terms of the settlement agreement, CVS Health and CVS Pharmacy will settle all opioid claims against them and their subsidiaries by the State of Florida for $484 million, which is to be paid over a period of 18 years. Under the agreement, local municipalities within the State of Florida have 30 days to determine whether they will join the settlement negotiated by the State of Florida. At the conclusion of the 30-day period, CVS Health and CVS Pharmacy have the option to not proceed with the settlement if they determine that a sufficient number of municipalities have not agreed to join the settlement. As a result of this settlement, CVS Health and CVS Pharmacy will no longer be defendants in the State of Florida's opioid lawsuit that is scheduled for trial in April 2022.

A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.




  Item 9.01 Financial Statements and Exhibits.




(d)           Exhibits.

Exhibit No.   Description
  99.1          Press Release, dated March 30, 2022  .
104           Cover Page Interactive Data File (embedded within the Inline XBRL).

© Edgar Online, source Glimpses